Ngā hua rapu - Taijun Yunoki
- E whakaatu ana i te 1 - 2 hua o te 2
-
1
Rivaroxaban and Apixaban Reduce Hemorrhagic Transformation After Thrombolysis by Protection of Neurovascular Unit in Rat mā Syoichiro Kono, Toru Yamashita, Kentaro Deguchi, Yoshio Omote, Taijun Yunoki, Kota Sato, Tomoko Kurata, Nozomi Hishikawa, Koji Abe
I whakaputaina 2014Artigo -
2
Safety and Clinical Effects of a Muse Cell-Based Product in Patients With Amyotrophic Lateral Sclerosis: Results of a Phase 2 Clinical Trial mā Toru Yamashita, Yumiko Nakano, Ryo Sasaki, Koh Tadokoro, Yoshio Omote, Taijun Yunoki, Yuko Kawahara, Namiko Matsumoto, Yuki Taira, Chika Matsuoka, Ryuta Morihara, Koji Abe
I whakaputaina 2023Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Anesthesia
Internal medicine
Medicine
Adverse effect
Amyotrophic lateral sclerosis
Apixaban
Atrial fibrillation
Cardiology
Cerebrospinal fluid
Clinical endpoint
Clinical trial
Disease
Engineering
Gastroenterology
Mechanical engineering
Myocardial infarction
Neurovascular bundle
Oncology
Riluzole
Rivaroxaban
Stroke (engine)
Surgery
Thrombolysis
Tolerability
Warfarin